Flora Growth Corp. Amends 8-K Filing on Asset Acquisition
Ticker: ZSTK · Form: 8-K/A · Filed: Jun 4, 2024 · CIK: 1790169
| Field | Detail |
|---|---|
| Company | Flora Growth Corp. (ZSTK) |
| Form Type | 8-K/A |
| Filed Date | Jun 4, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, acquisition, financial-statements
TL;DR
Flora Growth Corp. filed an 8-K/A amendment on 6/4/24 regarding asset acquisition details.
AI Summary
Flora Growth Corp. filed an amendment (8-K/A) on June 4, 2024, to its previous report dated April 22, 2024. This amendment pertains to the completion of an acquisition or disposition of assets and includes financial statements and exhibits. The company's principal executive offices are located at 3230 W. Commercial Boulevard, Suite 180, Fort Lauderdale, Florida.
Why It Matters
This amendment clarifies details regarding a significant corporate transaction, potentially impacting investors' understanding of Flora Growth Corp.'s asset base and strategic direction.
Risk Assessment
Risk Level: low — This filing is an amendment to a previous report and primarily provides updated or clarified information rather than introducing new material risks.
Key Players & Entities
- Flora Growth Corp. (company) — Registrant
- 0001062993-24-011760 (filing_id) — Accession Number
- April 22, 2024 (date) — Date of earliest event reported
- June 4, 2024 (date) — Filing Date
- 3230 W. Commercial Boulevard, Suite 180, Fort Lauderdale, Florida, 33309 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K/A filing by Flora Growth Corp.?
The primary purpose of this 8-K/A filing is to amend a previous report concerning the completion of an acquisition or disposition of assets and to include financial statements and exhibits.
When was the original event reported by Flora Growth Corp. that this filing amends?
The original event reported by Flora Growth Corp. that this filing amends occurred on April 22, 2024.
What is the filing date of this amendment (8-K/A)?
The filing date of this amendment (8-K/A) is June 4, 2024.
Where are Flora Growth Corp.'s principal executive offices located?
Flora Growth Corp.'s principal executive offices are located at 3230 W. Commercial Boulevard, Suite 180, Fort Lauderdale, Florida, 33309.
What type of information is included in this amended filing besides the completion of an asset transaction?
This amended filing also includes financial statements and exhibits related to the asset transaction.
Filing Stats: 637 words · 3 min read · ~2 pages · Grade level 11 · Accepted 2024-06-04 16:01:17
Filing Documents
- form8ka.htm (8-K/A) — 16KB
- exhibit23-1.htm (EX-23.1) — 2KB
- exhibit99-1.htm (EX-99.1) — 198KB
- exhibit99-2.htm (EX-99.2) — 173KB
- exhibit99-3.htm (EX-99.3) — 316KB
- exhibit23-1xu001.jpg (GRAPHIC) — 10KB
- exhibit23-1xu002.jpg (GRAPHIC) — 9KB
- exhibit99-1xu003.jpg (GRAPHIC) — 12KB
- exhibit99-1xu004.jpg (GRAPHIC) — 12KB
- 0001062993-24-011760.txt ( ) — 1053KB
- flgc-20240422.xsd (EX-101.SCH) — 5KB
- flgc-20240422_cal.xml (EX-101.CAL) — 1KB
- flgc-20240422_def.xml (EX-101.DEF) — 22KB
- flgc-20240422_lab.xml (EX-101.LAB) — 46KB
- flgc-20240422_pre.xml (EX-101.PRE) — 25KB
- form8ka_htm.xml (XML) — 3KB
01 Completion of Acquisition or Disposition of Assets
Item 2.01 Completion of Acquisition or Disposition of Assets On April 23, 2024, Flora Growth Corp. (the "Company") filed a Current Report on Form 8-K (the "Original Form 8-K") to report the completion of the first closing of the acquisition of TruHC Pharma GmbH ("TruHC") . As permitted under Item 9.01 of Form 8-K, this Amendment No. 1 to the Current Report on Form 8-K amends and supplements the Original Form 8-K solely to provide the historical financial statements and the unaudited pro forma condensed combined financial information required under Item 9.01 of Form 8-K within 71 calendar days after the date on which the Original Form 8-K was required to be filed.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (a) Financial Statements of Business Acquired The financial statements of TruHC required to be filed pursuant to Rule 3-05 of Regulation S-X are filed as Exhibits 99.1 and 99.2 to this Current Report on Form 8-K/A and incorporated by reference herein. (b) Pro Forma Financial Information The unaudited pro forma condensed consolidated financial information of the Company required to be filed in connection with the acquisition and disposition described in Item 2.01 in the Original Form 8-K is filed as Exhibit 99.3 to this Current Report on Form 8-K/A and incorporated by reference herein. (d) Exhibits 23.1 Consent of Davidson & Company related to the financial statements of TruHC Pharma GmbH 99.1 Audited Financial Statements of TruHC Pharma GmbH as of and for the year ended December 31, 2023 99.2 Unaudited Financial Statements of TruHC Pharma GmbH as of and for the three months ended March 31, 2024 99.3 Unaudited Pro Forma Condensed Consolidated Financial Statements 104 Cover Page Interactive Data File
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. FLORA GROWTH CORP. Date: June 4, 2024 By: /s/ Clifford Starke Name: Clifford Starke Title: Chief Executive Officer